FDA approves the first device built to seal leaks around replaced heart valves
Abbott's Amplatzer Paraclose PVL Occluder is placed by catheter and is the first U.S.-approved device designed for paravalvular...
Created Stories
VUE Health Named Healthcare Advertising Agency of the Year 2026
Founder and CEO Kathryn Wilson also named one of the Top 10 Inspiring Women Entrepreneurs to Watch in...
FDA approves Hibsago, the first antisense drug for chronic hepatitis B, and what its trials actually showed
GSK's bepirovirsen is approved for a narrow group of adults with chronic hepatitis B. About one in five...
Civil Rights and Trial Attorney John Gomez Announces Wrongful Death Lawsuit After Developmentally Disabled Man Killed at Fallbrook Care Facility
Gomez Trial Attorneys and the family of Ryan Radabaugh allege Stepping Stone Resources failed to protect the 53-year-old...
University Medical Center Göttingen Takes a New Approach to the Use of Clinical Data
UMG is advancing its data integration center and becomes the first German university hospital to introduce MDClone's internationally...
AI in Clinical Trials Market to Reach USD 7.32 Billion by 2034 as AI Reshapes Patient Recruitment, Data Analysis and Drug Development, says Maximize Market Research
PUNE, India, Sept. 25, 2026 /PRNewswire/ -- The Global AI in Clinical Trials Market was valued at USD 2...
Global Nanomedicine Market to Reach USD 581.2 Bn. by 2034, Driven by Rising Chronic Disease Prevalence, Expanding Nanotechnology-Based Drug Delivery, and Advances in Precision Diagnostics and Therapeutics Says Maximize Market Research
PUNE, India, Sept. 24, 2026 /PRNewswire/ -- The Global Nanomedicine Market was valued at USD 207.91 Billion in 2025...
A Game Changer: Harold Hamm Commits Largest Gift in OU History to Lift Health of Oklahoma, Name Health Campus
OKLAHOMA CITY, Sept. 22, 2026 /PRNewswire/ -- The University of Oklahoma today announced an historic $150 million gift...
StimCardio’s NeuroPulse Study Reports Substantial Reduction in Recurrent Atrial Fibrillation Events Via Non-Invasive Wearable Neuromodulation Following Ablation
90% freedom from atrial arrhythmias at six months with neuromodulation vs. 80.8% with shamRandomized, double-blind, sham-controlled results presented...
Par Health Issues Voluntary Nationwide Recall of Two Lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection Due to the Presence of Particulate Matter
ROCHESTER, Mich., Sept. 18, 2026 /PRNewswire/ -- Par Health is voluntarily recalling two lots of Dexmedetomidine HCl in...
Armor Health Expands Structured Approach to Women’s Postpartum Mental Health in Correctional Settings
MIAMI, Sept. 16, 2026 /PRNewswire/ -- Armor Health (ArmorHealthcare.com), a national provider of correctional healthcare, is expanding its...
Houston Couple Brings a Personal Approach to Recovery and Wellness to the Energy Corridor with New beem® Studio
Locally owned wellness destination will offer private infrared sauna and red light therapy, with Founding Member rates available...